default author photo

Wei Kang

The Chinese University of Hong Kong (CUHK) - Department of Anatomical and Cellular Pathology

SCHOLARLY PAPERS

2

DOWNLOADS

142

TOTAL CITATIONS

0

Scholarly Papers (2)

Actions:
Email selected abstracts
1.

Development and Validation of a Machine Learning Based Plasma Biomarker Models Outperform Conventional Steatosis Index in Predicting MASLD

Number of pages: 35 Posted: 26 Jun 2025
Jialin Wu, Wenting Wei, Cheuk Fung Yip, Xinyi Deng, Yang Lyu, Peiyao Yu, Tiejun Feng, Bonan Chen, Fuda Xie, Ge Zhang, Ka Fai To and Wei Kang
The Chinese University of Hong Kong (CUHK) - State Key Laboratory of Translational Oncology, Sun Yat-sen University (SYSU) - Zhongshan School of Medicine, The Chinese University of Hong Kong (CUHK) - Department of Medicine & Therapeutics, Sun Yat-sen University (SYSU) - Zhongshan School of Medicine, The Chinese University of Hong Kong (CUHK) - State Key Laboratory of Translational Oncology, The Chinese University of Hong Kong (CUHK) - State Key Laboratory of Translational Oncology, The Chinese University of Hong Kong (CUHK) - State Key Laboratory of Translational Oncology, The Chinese University of Hong Kong (CUHK) - State Key Laboratory of Translational Oncology, The Chinese University of Hong Kong (CUHK) - State Key Laboratory of Translational Oncology, Hong Kong Baptist University, The Chinese University of Hong Kong (CUHK) - Department of Anatomical and Cellular Pathology and The Chinese University of Hong Kong (CUHK) - Department of Anatomical and Cellular Pathology
Downloads 102 (679,608)

Abstract:

Loading...

Metabolic Dysfunction-Associated Steatotic Liver Disease, Machine Learning, Biomarker, Predictive Model

2.

Anti-PD1-Induced p-FADD-CD8 T Cell Axis Determines the Therapeutic Efficacy in Hepatocellular Carcinoma

Number of pages: 42 Posted: 18 Apr 2024
Jiahuan Lu, Thomas Ting-Hei Chan, Yun Wang, Zhewen Xiong, Jingqing Li, Yixuan Zhang, Huanyu Wang, Jintian Chen, Weiqin Yang, Jing Wang, Yalin Tu, Howard Ho-Wai Leung, Raymond Wai-Ming Lung, Wei Kang, Man Tong, Dan Wang, Qi-Nian Wu, Zhaolei Zeng, Alfred Sze-Lok Cheng, Ka Fai To, Anthony Wing-Hung Chan and Jingying Zhou
The Chinese University of Hong Kong (CUHK), The Chinese University of Hong Kong (CUHK), Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China, The Chinese University of Hong Kong (CUHK), The Chinese University of Hong Kong (CUHK), The Chinese University of Hong Kong (CUHK), The Chinese University of Hong Kong (CUHK), The Chinese University of Hong Kong (CUHK), The Chinese University of Hong Kong (CUHK), The Chinese University of Hong Kong (CUHK), The Chinese University of Hong Kong (CUHK), The Chinese University of Hong Kong (CUHK), The Chinese University of Hong Kong (CUHK), The Chinese University of Hong Kong (CUHK) - Department of Anatomical and Cellular Pathology, The Chinese University of Hong Kong (CUHK), The Chinese University of Hong Kong (CUHK), Sun Yat-sen University (SYSU), Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China, The Chinese University of Hong Kong (CUHK), The Chinese University of Hong Kong (CUHK) - Department of Anatomical and Cellular Pathology, The Chinese University of Hong Kong (CUHK) and The Chinese University of Hong Kong (CUHK)
Downloads 40 (1,183,237)

Abstract:

Loading...

HCC immunophenotype, anti-PD1 treatment, FADD, tumor-infiltrating CD8+T cells, CCL5/CCR5, sequential combination of immunotherapy